India's Ranbaxy Sees Generic Deal For Nexium Kicking Off This Year
This article was originally published in PharmAsia News
A deal between Ranbaxy Laboratories and AstraZeneca for a generic version of the U.K.-based firm's proton pump inhibitor Nexium (esomeprazole) is set to take place by the end of this year, ending a delay of more than a year
You may also be interested in...
The proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.
Sanofi has named the head of its new API business; Sweden's Enzymatica has hired talent from J&J and L'Oreal; and Bayer has a new transformation officer.
The Global Self-Care Federation is looking to consolidate the shift towards self-care seen during the pandemic by promoting trust, innovation and growth in policy. An upcoming webinar hosted by the GSCF will also explore the theme of "Advancing Trust in the Self-Care Industry."